Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the fiscal 2018 second quarter ended Dec. 31 of $35.2 billion, a 6 percent increase compared to the same period a year ago. Profit was $1.1. billion, up from $324 million the same period a year ago.

Pharmaceutical segment sales increased 5 percent year-over-year to $31.1 billion. Segment profit decreased 4 percent to $514 million.

For the first six months, Cardinal Health reported sales of $67.8 billion, a 4 percent increase compared to the same period a year ago. Profit was $1.2. billion, up from $634 million the same period a year ago.